Concepedia

François-Xavier Ogi

FO

Statistics

Publications

3

Citations

305

H-Index

3

Active since

2003

Affiliations

NanoTemper Technologies (Germany)(Current)

François-Xavier Ogi is an author at NanoTemper Technologies (Germany) specializing in medicinal chemistry, drug design, and oncology.

Publications per year

2003–2017

3

Publications

3

Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies

Edurne San José‐Eneriz, Xabier Agirre, Obdulia Rabal et al. · Nature Communications · 2017 · 170 citations · Full text

, , +17

Involvement of the DNA Repair Protein hHR23 in p53 Degradation

Sandra Glockzin, François-Xavier Ogi, Arnd Hengstermann et al. · Molecular and Cellular Biology · 2003 · 94 citations · Full text

, , +15

Thrombospondin-1 Mimetic Agonist Peptides Induce Selective Death in Tumor Cells: Design, Synthesis, and Structure–Activity Relationship Studies

Thomas Denèfle, Héloïse Boullet, Linda Herbi et al. · Journal of Medicinal Chemistry · 2016 · 41 citations · Full text

, , +14

1–3 of 3